Cargando…
Genistein prevents bone loss in type 2 diabetic rats induced by streptozotocin
BACKGROUND: Diabetic osteoporosis has become a severe public health problem in the aging societies. Genistein has been reported to play an important role in preventing and treating metabolic diseases via its anti-inflammatory, antioxidant, anti-estrogenic, and estrogen-like functions. OBJECTIVE: We...
Autores principales: | Lu, Rongrong, Zheng, Zicong, Yin, Yimin, Jiang, Zhuoqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Academia
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778425/ https://www.ncbi.nlm.nih.gov/pubmed/33447176 http://dx.doi.org/10.29219/fnr.v64.3666 |
Ejemplares similares
-
Genistein attenuates renal fibrosis in streptozotocin-induced diabetic rats
por: Jia, Qiang, et al.
Publicado: (2019) -
Effect of genistein, a natural soy isoflavone, on pancreatic β-cells of streptozotocin-induced diabetic rats: Histological and immunohistochemical study
por: El-Kordy, Eman Ali, et al.
Publicado: (2015) -
Radiotherapy-induced bone deterioration is exacerbated in diabetic rats treated with streptozotocin
por: Jiang, Maogang, et al.
Publicado: (2021) -
Combination Therapies Prevent the Neuropathic, Proinflammatory Characteristics of Bone Marrow in Streptozotocin-Induced Diabetic Rats
por: Dominguez, James M., et al.
Publicado: (2015) -
Streptozotocin, Type I Diabetes Severity and Bone
por: Motyl, Katherine, et al.
Publicado: (2009)